Heidelberg Pharma logo

Heidelberg Pharma

Heidelberg Pharma is a biopharmaceutical company that focuses on oncology and antibody targeted amanitin conjugates (ATAC). Their innovations are based on cell immunotherapy and the drug amanitin conjugates (ATAC). The tumor cells are attacked by immune cells, which recognize the amanitin antigen as a foreign body. This way the treatment causes no mutilation of healthy tissue.

Latest events on Quartr

Upcoming events for Heidelberg Pharma

Previous Events for Heidelberg Pharma

Ticker

HPHA

Country

Germany

About the company

https://heidelberg-pharma.com/de/

Investor Relations page

https://heidelberg-pharma.com/de/presse-investoren/mitteilungen/finanzberichte

Dig deeper into the fundamentals using Quartr - Investor relations

  • Skip straight to the Q&A session
  • Receive notifications about new events
  • Connect the financial calender on your phone
  • Figure out why the stock is up or down
  • Read the transcripts or scroll the deck
  • Access earnings or press releases
Android play link
App store link
Quartr app screenshot